ADJUVANT COMPOSITION CONTAINING ALUMINUM, AND CONTAINING ITS VACCINE COMPOSITION Russian patent published in 2020 - IPC A61K39/00 A61K39/39 A61K47/14 A61K47/22 A61K47/02 A61P37/04 

Abstract RU 2721417 C2

FIELD: medicine; immunology.

SUBSTANCE: group of inventions can be used to produce an adjuvant composition. Adjuvant composition includes a pH-sensitive carrier; and at least one substance selected from a group consisting of aluminum hydroxide and aluminum phosphate. In which the pH-sensitive carrier contains at least one pH-sensitive compound selected from a group consisting of deoxycholic acid, cholic acid, ursodeoxycholic acid, chenodeoxycholic acid, gideoxycholic acid, higher bile acid, glycodeoxycholic acid, glycyrrhizic acid, glycyrrhetinic acid and salts thereof. Where one amphipathic substance is selected from a group consisting of phosphatidylcholine containing only an acyl group containing 10 to 12 carbon atoms, polyoxyethylene sorbitan ester and mono-fatty acid containing an acyl group containing 12 to 18 carbon atoms, a sorbitan ester and a fatty acid containing an acyl group only, containing 16 to 18 carbon atoms, glycerol monooleate, glycerol dilaurate, glycerol distearate, glycerol dioleate, polyoxyethylene castor oil and α-tocopherol. pH-sensitive carrier demonstrates effect of membrane destruction function promotion. Aluminum-containing substance is contained in amount of 1 to 100 mcg, per aluminum metal, per 100 nmol of amphipathic substance. Group of inventions also relates to a composition containing said adjuvant and antigen.

EFFECT: use of this group of inventions enables to obtain an adjuvant which induces cell-mediated immunity effectively through cross-presentation of the antigen.

5 cl, 7 ex, 2 tbl, 11 dwg

Similar patents RU2721417C2

Title Year Author Number
PH-SENSITIVE CARRIER AND METHOD FOR PRODUCTION THEREOF, PH-SENSITIVE MEDICINE AND PH-SENSITIVE PHARMACEUTICAL COMPOSITION EACH CONTAINING SAID CARRIER, AND CULTURE METHOD USING SAID PH-SENSITIVE MEDICINE OR SAID PH-SENSITIVE PHARMACEUTICAL COMPOSITION 2013
  • Sakaguti Naoki
RU2682249C2
NEW VACCINE COMPOSITIONS COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES 2014
  • Dominowski Paul Joseph
  • Rai Sharath K.
  • Sly Laurel Mary
  • Cook Corey Patrick
  • Mwangi Duncan
  • Foss Dennis L.
  • Krebs Richard Lee
RU2627447C2
NEW ADJUVANT COMPOSITIONS 2009
  • Bagi Sedo Martin
  • Chajlders Tedd Alan
  • Dominouski Pol Dzhozef
  • Krebs Richard Li
  • Mannan Ramasami Mannar
  • Olsen Mehri Kehtrin
  • Tompson Dzhejms Richard
  • Uiratna Risini Dammika
  • Jansi Robert Dzhon Ml.
  • Chzan Shuchen
RU2510280C2
COMPOSITION CONTAINING CHITOSAN FOR OCULAR ADMINISTRATION OF VACCINE (VACCINES) TO POULTRY 2009
  • Garden Jannik
  • Palija Vilmos
  • Kont Sil'Ven
RU2498818C2
COMPOSITION CONTAINING TLR AGONIST AND METHODS FOR ITS APPLICATION 2017
  • Foks Kristofer B.
RU2761870C2
NOVEL AMINOALKYLGLUCOSAMINIDE PHOSPHATE COMPOUNDS, IMMUNOSTIMULATING PHARMACEUTICAL COMPOSITION COMPRISING THEREOF AND METHOD FOR INDUCING IMMUNE RESPONSE 2002
  • Dzhonson Dejvid A.
  • Boldridzh Dzhouri R.
  • Sovel Greg
  • Klaff Kristofer V.
RU2289585C2
METHODS OF PRODUCING ADJUVANTED VIROSOME AND ADJUVANTED VIROSOMES, OBTAINED BY SAID METHODS 2014
  • Stegmann Antonius Jokhannes Khenrikus
  • Soej-Ken Ton Joan Klaudiya Mauren
RU2694367C2
IMMUNOGENIC COMPOSITIONS OF Bordetella bronchiseptica 2012
  • Abdelmagid Omar Yousif
  • Bricker Joseph Michael
  • Shields Shelly Lynn
  • Galvin Jeffrey E.
RU2554480C2
COMPOSITIONS FOR TREATING AND PREVENTING COMPLEX OF RESPIRATORY DISEASES IN DOGS 2012
  • Abdel'Magid Omar Jusif
  • Briker Dzhozef Majkl
  • Shilds Shelli Linn
RU2553222C2
VACCINE COMPOSITION CONTAINING RESPIRATORY-SYNCYTIAL VIRUS PROTEIN (VERSIONS) 1994
  • Dzheral'D E. Khehnkok
  • Dehn Dzh. Spilmehn
  • Patrik Dzh. Frenchik
RU2160119C2

RU 2 721 417 C2

Authors

Sakaguchi, Naoki

Dates

2020-05-19Published

2016-05-23Filed